Giving The Go-Ahead To Use "Hybrid" Embryos

Law360, New York (October 16, 2007, 12:00 AM EDT) -- The future for stem cell research in the U.K. is at a critical point. The U.K. Government is overhauling the seventeen year old regulatory regime governing use of embryonic stem cells, and, in tandem under the existing law, the U.K.’s regulatory body has been considering whether to permit research using so-called ‘hybrid’ or ‘chimeric’ embryos. Last month, the latter deliberations resulted in an ‘in principle’ decision from the Human Fertilisation and Embryology Authority (HFEA) that such research should be permitted under the existing law, but this...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.